Lifeward Ltd LFWD.OQ, LFWD.O is expected to show a rise in quarterly revenue when it reports results on March 5 (estimated) for the period ending December 31 2025
The Yokneam Israel-based company is expected to report a 4.2% increase in revenue to $7.861 million from $7.55 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for Lifeward Ltd is for a loss of $1.08 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Lifeward Ltd is $54.00, about 696.5% above its last closing price of $6.78
This summary was machine generated March 3 at 13:55 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments